What are the payment terms and lead times?

Payment terms include T/T, Western Union, and Money Gram. Lead time is within 15 workdays off-season and one month during peak season.

Anesthetic GMP OEM 2ml/0.2mg Dexmedetomidine Injection

Name: Anesthetic GMP OEM 2ml/0.2mg Dexmedetomidine Injection
Brand: Guangzhou Sinolead Biotech Co., Ltd.
SKU: 2122515985

Guangdong, ChinaGuangzhou Sinolead Biotech Co., Ltd.

US$0.10

30,000 Pieces

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Package

5AMP/Box

Composition

Dexmedetomidine Hydrochloride

Model NO.

2ml/0.2g

Transport Package

Free

Specification

2ml/0.2mg

Trademark

Sinolead

Origin

China

Key features

GMP Certified OEM Production: Manufactured under GMP standards with OEM customization options for packaging and composition.

Effective Sedation and Analgesia: Highly selective alpha-2 adrenergic agonist for sedation and pain relief in medical settings.

Versatile Clinical Applications: Suitable for ICU sedation, procedural sedation, and as an adjunct to general anesthesia.

Precise Dosage Formulation: Available in 2ml/0.2mg concentration, packaged as 5 ampoules per box.

Global Market Reach: Exported to North America, South America, Europe, Asia, Africa, and Oceania.

Flexible Payment Terms: Accepts T/T, Western Union, Money Gram, and small-amount payments.

Reliable Supply Chain: Average lead time within 15 workdays off-season, one month during peak season.

Established Export Experience: Over 15 years of export experience since 2005 with multiple port options.

Company profile

Importers and Exporters

Guangzhou Sinolead Biotech Co., Ltd.

Guangdong, China

Business Type: Manufacturer/Factory, Trading Company, Group CorporationExport Year: 2005-06-16Nearest Port: Guangzhou, Shenzhen, Hong KongAverage Response Time: ≤15hTerms of Payment: T/T, Western Union, Small-amount payment, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, EXW

AI-Powered supplier vetting

SummaryThe supplier is a pharmaceutical and healthcare product manufacturer with products including glutathione, ceftriaxone sodium, amoxicillin/clavulanate, and customized generics. It reports multiple management, quality, environmental, occupational safety, and pharmaceutical certifications, along with 50 R&D engineers and 50 quality-control staff. Production information confirms several pharmaceutical dosage forms, but does not provide a directly comparable capacity figure. The supplier supports sample-based, flexible, and minor customization, but explicitly lacks ODM services, SDK availability, and recent new-product development. Service procedures exist for supplier approval, assessment, and corrective actions, although records are incomplete; complaint handling has both a clear procedure and follow-up records. It has no overseas warehouse, showroom, agents, branches, or offline trade-show experience. The company states that it has registered hundreds of pharmaceutical and healthcare products worldwide and...

Supplier typeThe supplier is positioned as a pharmaceutical and healthcare manufacturer, with listed products such as injectable ceftriaxone, glutathione, oral suspension, and customized generics. Its stated activities also include supporting product registration and regulatory dossier compliance, indicating a manufacturing-oriented pharmaceutical supplier rather than a general trading-only provider.

CertificationsThe supplier lists a broad range of certifications and management-system standards, including GMP, ISO 9001, ISO 14001, ISO 14000, HACCP, BSCI, OHSAS/OHSMS 18001, and others. The slice identifies certification holdings but does not provide certificate numbers, validity periods, or scope details.

After-Sales capabilityThe supplier has a clear complaint-handling procedure with followed records, and it accepts multiple service quotation and payment terms with stated lead times within 15 working days in both peak and off-season. However, it has no overseas warehouse, showroom, overseas agents or branches, and has no overseas-service country coverage, limiting evidence of localized after-sales support.

R&D capabilityThe supplier reports 50 R&D engineers, but explicitly states that it had no new products during the past year and no available SDK. It also does not provide ODM services, so the evidence shows established R&D staffing but limited demonstrated recent innovation.

Production capacityThe supplier lists production of multiple pharmaceutical products and dosage forms, including tablets, injections, and oral suspension, and identifies pharmaceuticals and customized generics among its product keywords. It also reports 50 quality-control staff, but the provided production-output statement is not a directly usable capacity metric for comparison.

Customization capabilityThe supplier explicitly offers customization from samples, flexible customization, and minor customization. This supports tailored production, although the supplier separately states that it does not provide ODM services.

Product Q&A

Q:What is the primary use of Dexmedetomidine Hydrochloride Injection?

It is primarily used as a sedative and analgesic agent, acting as a highly selective alpha-2 adrenergic agonist for sedation and pain relief.

Q:In which medical scenarios is this injection indicated?

It is indicated for ICU sedation of mechanically ventilated patients, procedural sedation (e.g., bronchoscopy, MRI), and as an adjunct to general anesthesia.

Q:How is the dosage administered?

It is typically administered as a continuous intravenous infusion under the supervision of healthcare professionals, with dosage adjusted based on patient factors.

Q:What precautions should be taken during use?

Use with caution in patients with pre-existing cardiovascular conditions like heart block or bradycardia, and monitor vital signs closely during infusion.

Q:Is OEM customization available for this product?

Yes, OEM customization is available, specifically for package configuration (e.g., 5AMP/Box) and composition details.